Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-01

Clinical Trial Update: Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating stem cell mobilization and VEGF gene transfer for ischemic heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Losordo, Douglas, M.D. | Conditions: Ischemic Congestive Heart Failure (CHF) | Phase 1 | Status: WITHDRAWN